Answers are grounded in this paper and cite their sources.
Background/Objectives: Altered superoxide dismutase 1 (SOD1) has been implicated in Parkinson’s disease (PD), but its immunohistochemical distribution in neuromelanin-containing nigral neurons warrants further characterization. We compared SOD1 immunoreactivity in post-mortem substantia nigra pars compacta (SNpc) tissue from PD patients and controls. Methods: Formalin-fixed, paraffin-embedded SNpc sections from five PD patients and five controls were examined. SOD1-immunopositive and immunonegative neuromelanin-containing neurons were counted across 15 operator-selected microscopic fields per subject. Subject-level percentages were compared using the two-sided exact Mann–Whitney U test. Results: All evaluable neurons in PD samples were SOD1-immunopositive (314/314; 100% in each subject), compared with 1031/1085 (95.0%) in controls. Median subject-level positivity was 100% in PD and 95.22% in controls (U = 25; p = 0.0079). Immunostaining appeared more intense in PD neurons, particularly near neuromelanin, although staining intensity was not quantified. Conclusions: PD samples showed a higher proportion of SOD1-immunopositive neurons and qualitatively stronger staining than controls. These preliminary observations do not establish increased intracellular SOD1 protein abundance or distinguish native from misfolded or aggregated SOD1. Further quantitative and biochemical investigations are warranted.
No takes yet. Share an insight, caveat, or question.
Schillaci et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: